Mark Jit
#125,316
Most Influential Person Now
Researcher
Mark Jit's AcademicInfluence.com Rankings
Mark Jitcomputer-science Degrees
Computer Science
#5228
World Rank
#5522
Historical Rank
Machine Learning
#1304
World Rank
#1324
Historical Rank
Artificial Intelligence
#1542
World Rank
#1571
Historical Rank
Database
#2380
World Rank
#2495
Historical Rank
Download Badge
Computer Science
Mark Jit's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Mark Jit Influential?
(Suggest an Edit or Addition)Mark Jit's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases (2008) (2491)
- Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts (2020) (2161)
- Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England (2020) (1894)
- The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study (2020) (1748)
- Age-dependent effects in the transmission and control of COVID-19 epidemics (2020) (1389)
- Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study (2020) (706)
- Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment (2021) (672)
- Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study (2020) (663)
- Projecting social contact matrices in 152 countries using contact surveys and demographic data (2017) (662)
- Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 (2021) (656)
- Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study (2020) (654)
- Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. (2012) (374)
- Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England (2020) (356)
- Economic evaluation of human papillomavirus vaccination in the United Kingdom (2008) (297)
- Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries (2020) (291)
- Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection (2020) (220)
- The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories (2020) (211)
- Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study. (2014) (203)
- Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models (2016) (199)
- The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. (2014) (197)
- Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation. (2010) (196)
- The effect of control strategies that reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China (2020) (186)
- The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study (2016) (175)
- Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination. (2007) (166)
- COVID-19 vaccine challenges: What have we learned so far and what remains to be done? (2021) (158)
- Using a real-world network to model localized COVID-19 control strategies (2020) (153)
- Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models (2016) (152)
- Accounting for Methodological, Structural, and Parameter Uncertainty in Decision-Analytic Models (2011) (144)
- Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study (2020) (135)
- Modelling the transmission of healthcare associated infections: a systematic review (2013) (133)
- Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England☆ (2013) (132)
- Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model (2011) (131)
- What types of contacts are important for the spread of infections?: using contact survey data to explore European mixing patterns. (2011) (130)
- The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe. (2009) (122)
- Estimation of the impact of genital warts on health-related quality of life (2008) (121)
- Global Case-Fatality Rates in Pediatric Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis (2019) (121)
- Adjusting for Inflation and Currency Changes Within Health Economic Studies. (2019) (117)
- Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections (2020) (114)
- Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review. (2013) (112)
- A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix® and Gardasil® Human Papillomavirus Vaccines in 12-15 Year Old Girls (2013) (111)
- Social contact patterns relevant to the spread of respiratory infectious diseases in Hong Kong (2017) (111)
- Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease. (2007) (107)
- Modelling the Epidemiology of Infectious Diseases for Decision Analysis (2011) (106)
- Projecting contact matrices in 177 geographical regions: An update and comparison with empirical data for the COVID-19 era (2020) (104)
- Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections (2020) (102)
- Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom. (2010) (101)
- Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries (2012) (100)
- Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis. (2015) (97)
- The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation (2020) (97)
- The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK (2011) (95)
- Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community (2015) (95)
- A systematic review of the social and economic burden of influenza in low- and middle-income countries. (2015) (94)
- Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines (2014) (94)
- Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study (2021) (92)
- The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysis. (2010) (89)
- The impact of COVID-19 control measures on social contacts and transmission in Kenyan informal settlements (2020) (89)
- Response strategies for COVID-19 epidemics in African settings: a mathematical modelling study (2020) (89)
- Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study (2020) (88)
- Dedicated outreach service for hard to reach patients with tuberculosis in London: observational study and economic evaluation (2011) (85)
- The broader economic impact of vaccination: reviewing and appraising the strength of evidence (2015) (82)
- The Impact of Pandemic Influenza H1N1 on Health-Related Quality of Life: A Prospective Population-Based Study (2011) (80)
- Health and economic impact of the seasonal influenza vaccination programme in England. (2012) (77)
- Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report. (2018) (77)
- Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions. (2013) (76)
- Mortality in Pediatric Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis (2019) (75)
- Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model (2015) (75)
- Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials (2019) (71)
- Patterns of human social contact and contact with animals in Shanghai, China (2019) (70)
- Controlling measles using supplemental immunization activities: A mathematical model to inform optimal policy (2015) (68)
- Reduction in wound infection rates by wound surveillance with postdischarge follow‐up and feedback (2006) (65)
- Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study. (2014) (65)
- Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR (2018) (64)
- 7-Valent Pneumococcal Conjugate Vaccination in England and Wales: Is It Still Beneficial Despite High Levels of Serotype Replacement? (2011) (63)
- Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England (2017) (62)
- Antimicrobial Resistance in the Asia Pacific region: a meeting report (2019) (62)
- Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs. (2018) (60)
- Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis (2019) (58)
- Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis (2018) (58)
- Prevalence of human papillomavirus antibodies in young female subjects in England (2007) (57)
- Burden of Severe Pneumonia, Pneumococcal Pneumonia and Pneumonia Deaths in Indian States: Modelling Based Estimates (2015) (57)
- Within-host dynamics shape antibiotic resistance in commensal bacteria (2018) (56)
- The effect of travel restrictions on the geographical spread of COVID-19 between large cities in China: a modelling study (2020) (54)
- The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries. (2018) (53)
- Discounting in the evaluation of the cost-effectiveness of a vaccination programme: A critical review. (2015) (53)
- Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With Men (2016) (52)
- Who should be prioritized for COVID-19 vaccination in China? A descriptive study (2020) (52)
- Human papillomavirus DNA in men who have sex with men: type-specific prevalence, risk factors and implications for vaccination strategies (2014) (52)
- Determining environmental and anthropogenic factors which explain the global distribution of Aedes aegypti and Ae. albopictus (2018) (51)
- The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey (2015) (51)
- Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC) (2020) (51)
- Reassessing the value of vaccines. (2014) (50)
- Prevalence of Human Papillomavirus Antibodies in Males and Females in England (2011) (50)
- Impact of measles supplementary immunization activities on reaching children missed by routine programs. (2018) (49)
- Acceptability and uptake of female adolescent HPV vaccination in Hong Kong: a survey of mothers and adolescents. (2013) (49)
- Oral Human Papillomavirus Infection in Men Who Have Sex with Men: A Systematic Review and Meta-Analysis (2016) (48)
- Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance. (2017) (48)
- How many are at increased risk of severe COVID-19 disease? Rapid global, regional and national estimates for 2020 (2020) (47)
- Influenza vaccines in low and middle income countries (2013) (47)
- Mathematical Modelling Long-Term Effects of Replacing Prevnar7 with Prevnar13 on Invasive Pneumococcal Diseases in England and Wales (2012) (47)
- Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models (2011) (46)
- An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe". (2010) (46)
- Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22–23 March 2017 (2018) (46)
- Oral human papillomavirus (HPV) infection in men who have sex with men: prevalence and lack of anogenital concordance (2015) (46)
- The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales. (2010) (46)
- Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis. (2013) (46)
- Estimating Progression Rates for Human Papillomavirus Infection From Epidemiological Data (2010) (45)
- Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world (2011) (45)
- Systematic review of model-based cervical screening evaluations (2015) (43)
- Cost of Treatment and QALYs Lost Due to Genital Warts: Data for the Economic Evaluation of HPV Vaccines in the United Kingdom (2009) (43)
- Mortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: a national matched cohort study (2021) (43)
- The impact of local and national restrictions in response to COVID-19 on social contacts in England: a longitudinal natural experiment (2021) (42)
- Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study. (2013) (42)
- Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis (2016) (42)
- Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules (2019) (41)
- A cross-sectional analysis of meteorological factors and SARS-CoV-2 transmission in 409 cities across 26 countries (2021) (41)
- Excess length of stay and mortality due to Clostridium difficile infection: a multi-state modelling approach. (2014) (41)
- Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies (2013) (41)
- The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England. (2012) (41)
- A global agenda for older adult immunization in the COVID-19 era: A roadmap for action (2020) (41)
- Quantifying the economic cost of antibiotic resistance and the impact of related interventions: rapid methodological review, conceptual framework and recommendations for future studies (2020) (40)
- Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries (2021) (39)
- Estimating the Number of Deaths with Rotavirus as a Cause in England and Wales (2007) (39)
- Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination (2019) (38)
- Mathematical modelling for antibiotic resistance control policy: do we know enough? (2019) (37)
- Seasonal influenza vaccination delivery through community pharmacists in England: evaluation of the London pilot (2016) (37)
- Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling study (2022) (36)
- Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries (2020) (36)
- Calibration of Complex Models through Bayesian Evidence Synthesis (2015) (35)
- Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study (2020) (35)
- Guidelines for multi-model comparisons of the impact of infectious disease interventions (2019) (34)
- Estimating number of cases and spread of coronavirus disease (COVID-19) using critical care admissions, United Kingdom, February to March 2020 (2020) (34)
- HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control (2019) (33)
- Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland. (2011) (33)
- Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts (2013) (33)
- Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization (2015) (33)
- Two-dose strategies for human papillomavirus vaccination: how well do they need to protect? (2014) (32)
- Evaluating the potential risks and benefits of infant rotavirus vaccination in England. (2014) (31)
- Access and Unmet Needs of Orphan Drugs in 194 Countries and 6 Areas: A Global Policy Review With Content Analysis. (2020) (30)
- Household Catastrophic Healthcare Expenditure and Impoverishment Due to Rotavirus Gastroenteritis Requiring Hospitalization in Malaysia (2015) (30)
- Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted Patients (2018) (29)
- Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study (2017) (29)
- Contact tracing is an imperfect tool for controlling COVID-19 transmission and relies on population adherence (2021) (28)
- Short-term forecasts to inform the response to the COVID-19 epidemic in the UK (2020) (28)
- Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: quantification using a multi-type mathematical model. (2012) (27)
- Estimating costs of care for meningitis infections in low- and middle-income countries. (2015) (26)
- Projected epidemiological consequences of the Omicron SARS-CoV-2 variant in England, December 2021 to April 2022 (2021) (26)
- Assessing dengue vaccination impact: Model challenges and future directions. (2016) (26)
- Estimating the opportunity costs of bed‐days (2017) (26)
- Cost-benefit analysis of vaccination: a comparative analysis of eight approaches for valuing changes to mortality and morbidity risks (2018) (26)
- Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible? (2016) (26)
- Exploring surveillance data biases when estimating the reproduction number: with insights into subpopulation transmission of COVID-19 in England (2020) (25)
- Economic costs and health-related quality of life for hand, foot and mouth disease (HFMD) patients in China (2017) (25)
- The impact of influenza on the health related quality of life in China: an EQ-5D survey (2017) (25)
- Economic Evaluations of Childhood Influenza Vaccination (2012) (24)
- A brief history of economic evaluation for human papillomavirus vaccination policy. (2010) (24)
- The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant (2021) (24)
- Estimating the impact of reopening schools on the reproduction number of SARS-CoV-2 in England, using weekly contact survey data (2021) (24)
- Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines (2016) (23)
- The impact of Coronavirus disease 2019 (COVID-19) on health systems and household resources in Africa and South Asia (2020) (22)
- The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya (2020) (21)
- Quantifying the public's view on social value judgments in vaccine decision-making: A discrete choice experiment. (2019) (21)
- The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness – A systematic review (2019) (21)
- Seropositivity to non-vaccine incorporated genotypes induced by the bivalent and quadrivalent HPV vaccines: A systematic review and meta-analysis. (2017) (21)
- The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy. (2016) (20)
- Trends in parameterization, economics and host behaviour in influenza pandemic modelling: a review and reporting protocol (2013) (20)
- Stakeholders’ perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study (2015) (20)
- Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature. (2018) (20)
- COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness (2021) (20)
- Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis (2021) (20)
- Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation. (2019) (20)
- Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world (2021) (20)
- Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era (2022) (19)
- POLYMOD social contact data (2017) (19)
- Meeting Report: WHO Workshop on modelling global mortality and aetiology estimates of enteric pathogens in children under five. Cape Town, 28–29th November 2018 (2020) (19)
- Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial) (2018) (18)
- Targeted vaccination in healthy school children - Can primary school vaccination alone control influenza? (2015) (18)
- The effect of inter-city travel restrictions on geographical spread of COVID-19: Evidence from Wuhan, China (2020) (18)
- Determinants of MRSA prevalence in the Asia Pacific Region : a systematic review and meta-analysis (2019) (18)
- Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic (2021) (18)
- Incidence and disease burden of herpes zoster in the population aged ≥50 years in China: Data from an integrated health care network. (2020) (17)
- Systematic review of economic evaluations of vaccination programs in mainland China: Are they sufficient to inform decision making? (2015) (17)
- Target immunity levels for achieving and maintaining measles elimination (2017) (17)
- The cost-effectiveness of rotavirus vaccination in Armenia. (2011) (17)
- Estimating the health impact of vaccination against 10 pathogens in 98 low and middle income countries from 2000 to 2030 (2019) (17)
- Quantifying Parameter and Structural Uncertainty of Dynamic Disease Transmission Models Using MCMC (2015) (17)
- The need for sustainability and alignment of future support for National Immunization Technical Advisory Groups (NITAGs) in low and middle-income countries (2018) (17)
- Implications of the school-household network structure on SARS-CoV-2 transmission under school reopening strategies in England (2021) (17)
- Comparison of Public Responses to Containment Measures During the Initial Outbreak and Resurgence of COVID-19 in China: Infodemiology Study (2021) (16)
- Modeling the impact of rubella vaccination in Vietnam (2016) (16)
- Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination (2014) (16)
- Benefit-risk analysis of health benefits of routine childhood immunisation against the excess risk of SARS-CoV-2 infections during the Covid-19 pandemic in Africa (2020) (16)
- The Full Value of Vaccine Assessments (FVVA): A Framework to Assess and Communicate the Value of Vaccines for Investment and Introduction Decision Making (2021) (16)
- Burden, duration and costs of hospital bed closures due to acute gastroenteritis in England per winter, 2010/11–2015/16 (2017) (16)
- A bibliometric analysis of systematic reviews on vaccines and immunisation (2018) (16)
- Cost-effectiveness of introducing national seasonal influenza vaccination for adults aged 60 years and above in mainland China: a modelling analysis (2020) (15)
- Informing Global Cost-Effectiveness Thresholds Using Country Investment Decisions: Human Papillomavirus Vaccine Introductions in 2006-2018. (2020) (15)
- Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia (2017) (15)
- Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review (2021) (15)
- Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden (2022) (15)
- Thresholds for decision-making: informing the cost-effectiveness and affordability of rotavirus vaccines in Malaysia (2018) (14)
- Restructuring routine elective services to reduce overall capacity requirements within a local health economy (2008) (14)
- Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England (2021) (14)
- PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer (2018) (14)
- Proceedings of the Modeling Evidence in HPV Pre-Conference Workshop in Malmö, Sweden, May 9-10, 2009. (2010) (14)
- Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines (2020) (14)
- Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease (2019) (14)
- Predicting the life-time benefit of school-based smoking prevention programmes. (2010) (14)
- An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations (2021) (14)
- Determinants of methicillin-resistant Staphylococcus aureus (MRSA) prevalence in the Asia-Pacific region: A systematic review and meta-analysis. (2019) (14)
- Projections of COVID-19 epidemics in LMIC countries (2020) (14)
- The contribution of hospital-acquired infections to the COVID-19 epidemic in England in the first half of 2020 (2021) (14)
- Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in England (2019) (14)
- Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework (2017) (14)
- Use of measles supplemental immunization activities (SIAs) as a delivery platform for other maternal and child health interventions: opportunities and challenges. (2013) (13)
- Estimating burden of influenza‐associated influenza‐like illness and severe acute respiratory infection at public healthcare facilities in Romania during the 2011/12‐2015/16 influenza seasons (2017) (13)
- Clustering of contacts relevant to the spread of infectious disease. (2016) (13)
- Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis (2018) (13)
- Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European Region: a mathematical modelling study (2021) (13)
- Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries (2021) (13)
- Infant hospitalisations and fatalities averted by the maternal pertussis vaccination programme in England, 2012-2017: Post-implementation economic evaluation. (2020) (12)
- Chlamydia sequelae cost estimates used in current economic evaluations: does one-size-fit-all? (2016) (12)
- Current Global Pricing For Human Papillomavirus Vaccines Brings The Greatest Economic Benefits To Rich Countries. (2016) (12)
- Modelling the potential consequences of the Omicron SARS-CoV-2 variant in England (12)
- Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study (2021) (12)
- Understanding differences in cervical cancer incidence in Western Europe: comparing Portugal and England (2018) (11)
- Real-time monitoring of COVID-19 dynamics using automated trend fitting and anomaly detection (2020) (11)
- Potential lives saved in 73 countries by adopting multi‐cohort vaccination of 9–14‐year‐old girls against human papillomavirus (2018) (11)
- Age-structured SEIR model for COVID-19 outbreak in Wuhan, China (2020) (11)
- The Hidden Health and Economic Burden of Rotavirus Gastroenteritis in Malaysia: An Estimation Using Multiple Data Sources (2016) (10)
- Association of enteropathogen detection with diarrhoea by age and high versus low child mortality settings: a systematic review and meta-analysis (2021) (10)
- The impact of vaccination on gender equity: conceptual framework and human papillomavirus (HPV) vaccine case study (2020) (10)
- Research Summary: The development and implementation of NHS Treatment Centres as an organisational innovation (2008) (10)
- How can the public health impact of vaccination be estimated? (2021) (10)
- Social contact patterns relevant to the spread of respiratory infectious diseases in Hong Kong (2017) (10)
- The effect of international travel restrictions on internal spread of COVID-19 (2020) (10)
- Evaluating the use of the reproduction number as an epidemiological tool, using spatio-temporal trends of the Covid-19 outbreak in England (2020) (10)
- Within-host dynamics explain the coexistence of antibiotic-sensitive and resistant bacteria (2017) (10)
- Divergent vaccination policies could fuel mistrust and hesitancy (2021) (10)
- Caregiver and service provider vaccine confidence following the Changchun Changsheng vaccine incident in China: A cross-sectional mixed methods study (2020) (10)
- Comparing human and model-based forecasts of COVID-19 in Germany and Poland (2021) (9)
- The allocation of COVID-19 vaccines and antivirals against emerging SARS-CoV-2 variants of concern in East Asia and Pacific region: A modelling study (2022) (9)
- Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT. (2020) (9)
- How to take variability into account when planning the capacity for a new hospital unit (2005) (9)
- Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries (2020) (9)
- Exploring equity in health and poverty impacts of control measures for SARS-CoV-2 in six countries (2021) (9)
- Using high-resolution contact networks to evaluate SARS-CoV-2 transmission and control in large-scale multi-day events (2021) (9)
- From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness (2020) (8)
- Global diarrhoea-associated mortality estimates and models in children: Recommendations for dataset and study selection. (2021) (8)
- The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study (2022) (8)
- Effect of Pediatric Influenza Vaccination on Antibiotic Resistance, England and Wales (2020) (8)
- School-based interventions to prevent the uptake of smoking among children and young people: cost-effectiveness model (2009) (8)
- Incidence and Disease Burden of Herpes Zoster in the Population Aged ≥50 Years in China: Data from an Integrated Health Care Network (2020) (7)
- The CAPACITI Decision-Support Tool for National Immunization Programs. (2021) (7)
- Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European Region (2021) (7)
- Travel measures in the SARS-CoV-2 variant era need clear objectives (2022) (7)
- Characterizing measles transmission in India: a dynamic modeling study using verbal autopsy data (2017) (7)
- The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models (2020) (7)
- Systematic Review on the Acute Cost-of-Illness of Sepsis and Meningitis in Neonates and Infants. (2019) (7)
- Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries (2020) (7)
- Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis (2022) (7)
- A Scoping Review of Investment Cases for Vaccines and Immunization Programs. (2019) (7)
- Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis (2021) (7)
- The role of vaccines in combating antimicrobial resistance (2020) (6)
- Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates (2018) (6)
- Comparative modelling of dengue vaccine public health impact ( CMDVI ) 17 / 03 / 2016 Authors (2016) (6)
- Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: a comparative modelling study (2021) (6)
- Mini-review: Can non-human leucocyte antigen genes determine susceptibility to severe dengue syndromes? (2017) (6)
- Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries (2019) (6)
- Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries (2021) (6)
- Rotavirus vaccines contribute towards universal health coverage in a mixed public–private healthcare system (2016) (6)
- Comparative modelling of dengue vaccine public health impact: Report to the World Health Organisation (2016) (6)
- Comparative effectiveness of allocation strategies of COVID-19 vaccines and antivirals against emerging SARS-CoV-2 variants of concern in East Asia and Pacific region (2021) (6)
- The economic burden of dengue: no longer invisible or unavoidable. (2016) (6)
- Determinants of RSV epidemiology following suppression through pandemic contact restrictions (2021) (6)
- The global impact and cost-effectiveness of a melioidosis vaccine (2019) (6)
- Integrating economic and health evidence to inform Covid-19 policy in low- and middle- income countries (2020) (6)
- Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem? (2021) (6)
- Health impact and cost-effectiveness of COVID-19 vaccination in Sindh Province, Pakistan (2021) (5)
- Building a new communication paradigm: Can we influence influenza perception? (2015) (5)
- Updated roadmap assessment: prior to delayed step 4 (5)
- Rapid COVID-19 vaccine rollout: immense success but challenges ahead (2021) (5)
- World Health Organization Expert Working Group: Recommendations for assessing morbidity associated with enteric pathogens (2021) (5)
- Health impact of routine immunisation service disruptions and mass vaccination campaign suspensions caused by the COVID-19 pandemic: Multimodel comparative analysis of disruption scenarios for measles, meningococcal A, and yellow fever vaccination in 10 low- and lower middle-income countries (2021) (5)
- Fewer than three doses of HPV vaccine. (2015) (5)
- Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose schedule (2021) (5)
- Quantifying long-term health and economic outcomes for survivors of group B Streptococcus invasive disease in infancy: protocol of a multi-country study in Argentina, India, Kenya, Mozambique and South Africa. (2020) (5)
- Behaviour, booster vaccines and waning immunity: modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era (2021) (5)
- Within-host dynamics explain patterns of antibiotic resistance in commensal bacteria (2018) (5)
- Social contact data for Hong Kong (2020) (5)
- Regional-based within-year seasonal variations in influenza-related health outcomes across mainland China: a systematic review and spatio-temporal analysis (2022) (5)
- Long-term health-related quality of life in non-hospitalised COVID-19 cases with confirmed SARS-CoV-2 infection in England: Longitudinal analysis and cross-sectional comparison with controls (2021) (5)
- MCDA from a health economics perspective: opportunities and pitfalls of extending economic evaluation to incorporate broader outcomes (2018) (5)
- A review of the costs of delivering maternal immunisation during pregnancy (2020) (4)
- Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore. (2021) (4)
- Effectiveness of infection prevention and control interventions, excluding personal protective equipment, to prevent nosocomial transmission of SARS-CoV-2: a systematic review and call for action (2021) (4)
- Research on the Health Inequalities Elements of the NHS Weighted Capitation Formula (2010) (4)
- Review of the current published evidence on single-dose HPV vaccination 2nd Edition (2019) (4)
- Optimal health and economic impact of non-pharmaceutical intervention measures prior and post vaccination in England: a mathematical modelling study (2021) (4)
- Cost-effectiveness of strategies for preventing paediatric lower respiratory infections associated with respiratory syncytial virus in eight Chinese cities. (2021) (4)
- WHO-led consensus statement on vaccine delivery costing: process, methods, and findings (2022) (4)
- Modeling the effect of vaccination on selection for antibiotic resistance in Streptococcus pneumoniae (2021) (4)
- Nosocomial Transmission of C. difficile in English Hospitals from Patients with Symptomatic Infection (2014) (4)
- Social contact data for China mainland (2019) (4)
- Neurodevelopmental and growth outcomes after invasive Group B Streptococcus in early infancy: A multi-country matched cohort study in South Africa, Mozambique, India, Kenya, and Argentina (2022) (4)
- Quantifying the Acute Care Costs of Neonatal Bacterial Sepsis and Meningitis in Mozambique and South Africa (2021) (3)
- A stochastic model to evaluate options for antenatal genetic screening (2006) (3)
- The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study (2023) (3)
- An integrated approach to evaluating alternative risk prediction strategies: a case study comparing alternative approaches for preventing invasive fungal disease. (2012) (3)
- Burden and Cost of Hospitalization for Respiratory Syncytial Virus in Young Children, Singapore (2020) (3)
- Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysis. (2021) (3)
- Effectiveness of CoronaVac and BNT162b2 COVID-19 mass vaccination in Colombia: A population-based cohort study (2022) (3)
- Estimating number of cases and spread of Coronavirus disease 2019 (COVID-19) in the United Kingdom using critical care admissions, February to March 2020 (2020) (3)
- Orphan drugs—access and unmet needs in 194 countries and six regions: a comprehensive policy review with content analysis (2019) (3)
- A Computational Algorithm Associated with Patient Progress Modelling (2007) (3)
- Shaping meeting to explore the value of a coordinated work plan for epidemic and pandemic influenza vaccine preparedness. (2020) (3)
- Response to comment on article by Jit et al. The cost effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe (2011) (3)
- SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study (2021) (3)
- Modelling borderline and mild dysplasia associated with HPV 6 and 11 infection. (2011) (3)
- Every Country, Every Family: Time to Act for Group B Streptococcal Disease Worldwide. (2021) (3)
- Differential health impact of intervention programs for time-varying disease risk: a measles vaccination modeling study (2022) (3)
- Interim roadmap assessment: prior to step 4 (2021) (3)
- Effectiveness of a pay-it-forward intervention compared with user-paid vaccination to improve influenza vaccine uptake and community engagement among children and older adults in China: a quasi-experimental pragmatic trial (2022) (3)
- Adding interventions to mass measles vaccinations in India (2016) (3)
- Multi-Country Model Application for RSV Cost-Effectiveness Policy (McMarcel) (2020) (2)
- Mapping the cryptic spread of the 2015–2016 global Zika virus epidemic (2020) (2)
- Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs. (2022) (2)
- Methods for Health Economic Evaluations of Vaccines - Results from an International Expert-Workshop. (2014) (2)
- Optimizing Benefits of Testing Key Workers for Infection with SARS-CoV-2: A Mathematical Modeling Analysis (2020) (2)
- Estimating RSV seasonality from pandemic disruptions: a modelling study (2022) (2)
- Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales (2022) (2)
- Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study (2022) (2)
- Modelling multi-site transmission of the human papillomavirus and its impact on vaccination effectiveness. (2017) (2)
- Global and national estimates of the number of healthcare workers at high risk of SARS-CoV-2 infection (2021) (2)
- The Cost-Effectiveness of Rotavirus Vaccination from Different Perspectives (2007) (2)
- Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods (2021) (2)
- The impact of COVID-19 vaccination in prisons in England and Wales: a metapopulation model (2022) (2)
- Point-of-care testing versus standard practice for chlamydia: a new approach to assessing the public health effect of rapid testing and treatment at local level (2014) (2)
- SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study (2021) (2)
- The impact of childhood pneumococcal conjugate vaccine immunisation on all-cause pneumonia admissions in Hong Kong: A 14-year population-based interrupted time series analysis. (2021) (2)
- HPV16 and HPV18 seropositivity and DNA detection among men who have sex with men: a cross-sectional study conducted in a sexual health clinic in London (2020) (2)
- Anal human papillomavirus prevalence and risk factors among men who have sex with men in Vietnam (2021) (2)
- Population-level risk factors related to measles case fatality: a conceptual framework and systematic review of evidence (2022) (2)
- The potential impact of novel tuberculosis vaccines on health equity and financial protection in low- and middle-income countries (2022) (2)
- Economic analysis of interventions against infectious diseases (2016) (2)
- Within-host dynamics shape antibiotic resistance in commensal bacteria (2019) (2)
- COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery (2022) (1)
- The effectiveness of pay-it-forward in addressing HPV vaccine delay and increasing uptake among 15–18-year-old adolescent girls compared to user-paid vaccination: a study protocol for a two-arm randomized controlled trial in China (2023) (1)
- Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC) (2020) (1)
- Considering equity in priority setting using transmission models: Recommendations and data needs (2022) (1)
- The potential for vaccination-induced herd immunity against SARS-CoV-2 (1)
- What makes an eLife paper in epidemiology and global health? (2015) (1)
- National Institute for Health Research Health Technology Assessment programme call (2013) (1)
- Competition and diversity determine vaccine impact on antibiotic resistance evolution (2019) (1)
- In Elimination Settings, Measles Antibodies Wane Following Vaccination but Not Following Infection - A Systematic Review and Meta-Analysis. (2022) (1)
- The potential impact and cost-effectiveness of current and future pneumococcal conjugate vaccines in India (2019) (1)
- Social contact and mixing patterns relevant to the spread of infectious diseases: a multi-country population-based survey (2007) (1)
- P08.29 Web-tool to assess the cost-effectiveness of chlamydia point-of-care tests at the local level (2015) (1)
- QUANTIFYING THE BENEFITS OF VACCINES IN COMBATING ANTIMICROBIAL RESISTANCE (2020) (1)
- How to Prevent Vaccines Falling Victim to Their Own Success: Intertemporal Dependency of Incidence Levels on Indirect Effects in Economic Reevaluations (2021) (1)
- RSV modelling meeting (2017) (1)
- Revisiting the winter burden of acute gastroenteritis on hospital beds in England: change in data collection supports analytical method for previously missing values. (2018) (1)
- Epidemiology of invasive fungal disease in UK critical care units (2013) (1)
- Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness (2022) (1)
- Estimating national-level measles case–fatality ratios in low-income and middle-income countries: an updated systematic review and modelling study (2023) (1)
- Using a real-world network to model localized COVID-19 control strategies (2020) (1)
- The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries (2022) (1)
- Quantifying long-term health and economic outcomes for survivors of group B Streptococcus invasive disease in infancy: protocol of a multi-country study in Argentina, India, Kenya, Mozambique and South Africa (2021) (1)
- Within-host competition determines vaccine impact on antibiotic resistance (2019) (1)
- Now or later: Health impacts of delaying single‐dose HPV vaccine implementation in a high‐burden setting (2022) (1)
- Comparison of Public Responses to Containment Measures During the Initial Outbreak and Resurgence of COVID-19 in China: Infodemiology Study (Preprint) (2020) (1)
- ND1 ACCESS AND UNMET NEEDS OF ORPHAN DRUGS IN 194 COUNTRIES AND SIX AREAS: A GLOBAL POLICY REVIEW WITH CONTENT ANALYSIS (2020) (1)
- Correction: COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness (2022) (1)
- The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: a modelling study (2022) (1)
- Cost-effectiveness of respiratory syncytial virus preventive interventions in children: a model comparison study. (2022) (1)
- Monitoring global trends in Covid-19 vaccination intention and confidence: a social media-based deep learning study (2021) (1)
- Estimating national-level measles case fatality ratios: an updated systematic review and modelling study (2022) (1)
- Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian Children. (2022) (1)
- Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis (2022) (1)
- DALY estimation for HPV vaccine impact on cervical cancer (2018) (0)
- Integrating economic and health evidence to inform Covid-19 policy in low- and middle- income countries. (2020) (0)
- How can early stage economic evaluation help guide research for future vaccines? (2021) (0)
- Application of a simple analytical model of capacity requirements (2005) (0)
- Mathematical Modelling of Cervical Cancer Vaccination in the UK (2008) (0)
- Methodological evolution of influenza vaccine effectiveness assessment (2016) (0)
- CAN PATIENT PROGRESS MODELLING INFORM THE MANAGEMENT OF CANCER PATIENTS (2007) (0)
- Pay-it-forward to improve influenza vaccine uptake and public engagement among children and older adults in China (2021) (0)
- HPV vaccinations—possibly necessary but not suffi cient (2014) (0)
- Winter burden of hospital bed closures due to acute gastroenteritis in England, 2010–11 to 2015–16: a population-based observational study (2016) (0)
- Systematic Review of Economic Evaluation Studies of Vaccines In China (2015) (0)
- Global spatiotemporal trends and determinants of COVID-19 vaccine acceptance on Twitter: a multilingual deep learning study in 135 countries and territories (2022) (0)
- Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low- and middle-income countries: a modelling study (2023) (0)
- Global Spatiotemporal Trends and Determinants of COVID-19 Vaccine Acceptance Expressed in Twitter: A Multilingual Deep Learning Study (2022) (0)
- The role of pneumococcal conjugate vaccination in reducing pneumonia mortality. (2019) (0)
- valuating the potential risks and benefits of infant rotavirus accination in England (2014) (0)
- Correction: Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis (2016) (0)
- What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in Nigeria (2023) (0)
- Development and validation of risk models for invasive Candida infection (2013) (0)
- The potential cost-effectiveness of HPV vaccination: a comparison of models from France and the UK (2007) (0)
- Application of a simple model of capacity requirements (2009) (0)
- Diagnostic delays: a patient’s story (2015) (0)
- 136:oral Optimising health benefit packages in the era of COVID-19: a case study from Pakistan (2022) (0)
- Medical Decision Making and MDM Policy & Practice Reviewers, 2018. (2019) (0)
- Date of introduction and epidemiologic patterns of SARS-CoV-2 in Mogadishu, Somalia: estimates from transmission modelling of 2020 excess mortality data (2021) (0)
- Simulation results for "COVID-19 vaccination in Sindh Province, Pakistan: a modelling study of health impact and cost-effectiveness" (2021) (0)
- Health and economic impact of delaying large-scale HPV vaccination and screening implementation on cervical cancer in China: a modelling study (2023) (0)
- A Modelling Study for Designing a Multi-layered Surveillance Approach to Detect the Potential Resurgence of SARS-CoV-2 (2020) (0)
- Participant information and drug resistance investigated (2015) (0)
- Approximating instantaneous vaccine efficacy from cumulative vaccine efficacy (2018) (0)
- Systematic review of the literature to identify risk factors for invasive fungal disease in critically ill adult patients (2013) (0)
- Impact of the 2018 Changchun Changsheng Vaccine Incident on Childhood Vaccination in China: Evidence From Vaccination Records and a National Survey (2022) (0)
- Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptions. (2022) (0)
- Potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study (2022) (0)
- Systematic review of model-based cervical screening evaluations (2015) (0)
- Date of introduction and epidemiologic patterns of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Mogadishu, Somalia: estimates from transmission modelling of satellite-based excess mortality data in 2020. (2021) (0)
- Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low- and middle-income countries: Report of an expert convening. (2023) (0)
- PIN42 Methodological Decisions in Economic Evaluations of Childhood Influenza Vaccination: Findings from a Literature Review (2011) (0)
- Evaluating the impact of Respiratory Syncytial Virus immunisation strategies on antibiotic use and drug resistant bacterial infections in England (2022) (0)
- Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countries. (2023) (0)
- Technical appendix to "The hidden health and economic burden of rotavirus gastroenteritis in Malaysia: an estimation using multiple data sources" (2016) (0)
- 91:oral The CAPACITI decision-support tool for national immunization programs prioritization or selecting among multiple vaccination products, services, or strategies (2022) (0)
- Full Title: Pay-it-forward to improve influenza vaccine uptake and public engagement among 1 children and older adults in China: A quasi-experimental pragmatic trial (2022) (0)
- Is there a role for RDTs as we live with COVID-19? An assessment of different strategies (2022) (0)
- Prevalence of human papillomavirus antibodies in young female subjects in England (2008) (0)
- Decision letter: The impact of measles immunization campaigns in India using a nationally representative sample of 27,000 child deaths (2019) (0)
- Machine learning as an alternative approach to developing risk models for invasive Candida infection (2013) (0)
- Pay-it-Forward to Improve Influenza Vaccine Uptake and Public Engagement Among Children and Older Adults in China: A Quasi-Experimental Pragmatic Trial (2022) (0)
- Exploring the subnational inequality and heterogeneity of the impact of routine measles immunisation in Africa. (2022) (0)
- Influenza vaccine uptake among children and older adults in China: a secondary analysis of a quasi-experimental study (2023) (0)
- When time-dependence in disease outcome risk is not captured by impact evaluation modeling studies: a measles vaccination case study (2021) (0)
- Economic modelling to assess the cost-effectiveness of prophylaxis based on the risk models for invasive Candida infection (2013) (0)
- Date of introduction and epidemiologic patterns of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Mogadishu, Somalia: estimates from transmission modelling of satellite-based excess mortality data in 2020 (2022) (0)
- Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a modeling analysis (2023) (0)
- High-dose influenza vaccines make economic sense for older people. (2015) (0)
- Medical Decision Making and MDM Policy & Practice Reviewers, 2018. (2019) (0)
- Prevalence and risk factors for human papillomavirus infection among female sex workers in Hanoi and Ho Chi Minh City, Viet Nam: a cross-sectional study (2022) (0)
- Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa (2022) (0)
- Effects of Demography, Disability Weights and Cervical Cancer Burden on HPV Vaccination Impact Estimates in 177 Countries: PRIME Modelling Study (2019) (0)
- Author's response to reviews Title:The broader economic impact of vaccination: reviewing and appraising the strength of evidence Authors: (2015) (0)
- Evaluating the impact of RSV immunisation strategies on antibiotic resistance in England (2021) (0)
- Time-and-motion analysis (2015) (0)
- Antimicrobial Resistance in the Asia Pacific region: a meeting report (2019) (0)
- EE622 Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Prevention Interventions in Children: A Model Comparison Study (2022) (0)
- Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza (2014) (0)
- Is the existing evidence about costs for outcomes associated with chlamydia sufficiently robust for economic evaluation of the National Chlamydia Screening Programme in England? (2015) (0)
- Economic Benefits To Rich Countries Current Global Pricing For Human Papillomavirus Vaccines Brings The Greatest (2016) (0)
- Can patients progress modelling inform the management of cancer patients (2007) (0)
- Authors’ Reply to Gandjour: “Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines” (2014) (0)
- Enzymes provide demographers with food for thought (2012) (0)
- Health-care costs and utilities (2015) (0)
- Assessing the impacts of COVID-19 vaccination programme’s timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries (2023) (0)
- Immunogenicity and seroefficacy of pneumococcal conjugate vaccines - a systematic review and network meta-analysis (2023) (0)
- Example of search strategy (2015) (0)
- Title Routine Pediatric Enterovirus 71 Vaccination in China : a Cost-Effectiveness Analysis (2016) (0)
- Optimal allocation strategies for HPV vaccination introduction and expansion in China accommodated to different supply and dose schedule scenarios: A modelling study (2022) (0)
- Timed tasks in the time-and-motion study (2015) (0)
- Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT) (2023) (0)
- Bibliography of included studies (2015) (0)
- Potential Benefit of Extended Dose Schedules of Human Papillomavirus (HPV) Vaccination in the Context of Limited Resources and COVID-19 Disruptions in Low- and Middle-Income Countries: A Mathematical Modeling Analysis. (2021) (0)
- Correction: The local burden of disease during the first wave of the COVID-19 epidemic in England: estimation using different data sources from changing surveillance practices (2022) (0)
- Placing a value on increased flexible vaccine manufacturing capacity for future pandemics (2023) (0)
- Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries (2023) (0)
- Pay-it-forward to improve influenza vaccine uptake and public engagement among children and older adults in China: A three-arm quasi-experimental study (2021) (0)
- Title: Pay-it-forward to improve influenza vaccine uptake and public engagement among children and older adults in China (2021) (0)
- Comparative assessment of methods for short-term forecasts of COVID-19 hospital admissions in England at the local level (2022) (0)
- Prevalence and Determinants of Vaginal Infection With Human Papillomavirus Among Female University Students in Vietnam (2021) (0)
- Dosing interval strategies for two-dose COVID-19 vaccination in 13 low- and middle-income countries of Europe: health impact modelling and benefit-risk analysis (2021) (0)
- Search strategy for systematic review (2013) (0)
- Data collection for risk factors and outcomes of invasive fungal disease (2013) (0)
- Assessing the impacts of timing on the health benefits, cost-effectiveness and relative affordability of COVID-19 vaccination programmes in 27 African Countries (2022) (0)
- Dynamic transmission model (2015) (0)
- Health impact of routine measles vaccination and supplementary immunisation activities in 14 high burden countries: a DynaMICE modelling study (2022) (0)
- Impact of pediatric influenza vaccination on antibiotic resistance in England and Wales (2019) (0)
- O06.4 Efficacy and cost-effectiveness of qHPV vaccine with imiquimod or podophyllotoxin for patients with anogenital warts (HIPvac) (2019) (0)
- Designing a multi-layered surveillance approach to detecting SARS-CoV-2: A modelling study (2020) (0)
- Study data extraction form screenshot (2015) (0)
- Designing a multi-layered surveillance approach to detecting SARS-CoV-2: A modelling study (2020) (0)
- Index and reference test information (2015) (0)
This paper list is powered by the following services:
Other Resources About Mark Jit
What Schools Are Affiliated With Mark Jit?
Mark Jit is affiliated with the following schools:
